novel policies aim to simplify test...

novel policies aim to simplify testing for single-pill combo and productions that combine drugs with medical devices.

In January, the meat and Drug Administration made headlines by the agency of quickly approving a fixed-dose-combination (FDC) treatment for AIDS subject to a new policy that allows its use in developing nations. Pharma manufacturers also are building commercial markets at to one's home for FDCs that furnish clinical benefit and/or reduced risk.

FDA is encouraging combo effect development by modifying preclinical and clinical testing requirements, and clarifying manufacturing standards for